1. Home
  2. SPRO vs CRMT Comparison

SPRO vs CRMT Comparison

Compare SPRO & CRMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Spero Therapeutics Inc.

SPRO

Spero Therapeutics Inc.

HOLD

Current Price

$2.24

Market Cap

124.5M

Sector

Health Care

ML Signal

HOLD

Logo America's Car-Mart Inc

CRMT

America's Car-Mart Inc

HOLD

Current Price

$12.80

Market Cap

105.4M

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPRO
CRMT
Founded
2013
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Specialty Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
124.5M
105.4M
IPO Year
2017
2026

Fundamental Metrics

Financial Performance
Metric
SPRO
CRMT
Price
$2.24
$12.80
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$29.50
AVG Volume (30 Days)
261.3K
192.6K
Earning Date
03-26-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
111.81
147.36
EPS
0.15
N/A
Revenue
$66,802,000.00
$1,390,932,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$4.57
P/E Ratio
$15.53
N/A
Revenue Growth
39.24
N/A
52 Week Low
$0.51
$11.04
52 Week High
$3.09
$62.55

Technical Indicators

Market Signals
Indicator
SPRO
CRMT
Relative Strength Index (RSI) 39.83 32.69
Support Level $2.15 $11.04
Resistance Level $2.44 $13.87
Average True Range (ATR) 0.13 1.27
MACD -0.02 0.17
Stochastic Oscillator 4.35 22.41

Price Performance

Historical Comparison
SPRO
CRMT

About SPRO Spero Therapeutics Inc.

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. Besides, it is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.

About CRMT America's Car-Mart Inc

America's Car-Mart Inc is an automotive retailer in the U.S. focused exclusively on the Integrated Auto Sales and Finance segment of the used car market. The company's operations are principally conducted through its two operating subsidiaries, America's Car Mart Inc and Colonial Auto Finance. It predominantly sells older model used vehicles and provides financing for substantially all of its customers. It earns revenue from the sale of used vehicles and, in the majority of cases, a related service contract and an accident protection plan product, as well as interest income and late fees from the related financing.

Share on Social Networks: